BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12497659)

  • 1. Surgical management of recurrent cervical cancer.
    Selman AE; Copeland LJ
    Yonsei Med J; 2002 Dec; 43(6):754-62. PubMed ID: 12497659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of recurrent cervical cancer.
    Dreyer G; Snyman LC; Mouton A; Lindeque BG
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):631-44. PubMed ID: 16150396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
    Davis MA; Adams S; Eun D; Lee D; Randall TC
    Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.
    Höckel M; Horn LC; Einenkel J
    Gynecol Oncol; 2012 Nov; 127(2):297-302. PubMed ID: 22864112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of advanced and recurrent cervical carcinoma: the place of pelvic exenteration.
    Monaghan JM
    Clin Obstet Gynaecol; 1985 Mar; 12(1):169-82. PubMed ID: 3888482
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of recurrences and follow-up of cervical cancers. Is there still a role for pelvic exenteration?].
    Michel G; Castaigne D; Morice P
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):195-6. PubMed ID: 9471459
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of recurrent cervical cancer: a review of the literature.
    Peiretti M; Zapardiel I; Zanagnolo V; Landoni F; Morrow CP; Maggioni A
    Surg Oncol; 2012 Jun; 21(2):e59-66. PubMed ID: 22244884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
    Sardain H; Lavoué V; Foucher F; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2016 Apr; 45(4):315-29. PubMed ID: 26874666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstruction of sigmoid vagina and conduit in total pelvic exenteration for recurrent cervical carcinoma.
    Shiromizu K; Ogawa M; Kotake K; Koyama Y; Nakazono M; Hirao K
    Jpn J Clin Oncol; 1989 Jun; 19(2):170-2. PubMed ID: 2733172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.
    Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC
    Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
    Chen M; Pan L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
    Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
    Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Manzour N; Vázquez-Vicente D; Carriles I; Boria F; Chacon E; Chiva L
    Int J Gynecol Cancer; 2021 Aug; 31(8):1188-1189. PubMed ID: 34031133
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of loco-regional recurrences of cervix cancers].
    Bobin JY; Romestaing P; Gérard JP
    Ann Chir; 1999; 53(9):904. PubMed ID: 10633941
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
    Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
    Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.